Related Experiment Videos
3H-Dopamine binding sites differ in rat striatum and pituitary
Naunyn-Schmiedeberg'S Archives of Pharmacology
|September 1, 1984
Summary
This study compared 3H-Domperidone binding sites in rat brain and pituitary, revealing distinct dopamine receptor subtypes in striatum versus pituitary. Findings highlight differences in drug binding affinities and receptor populations between these tissues.
Area of Science:
- Pharmacology
- Neuroscience
- Biochemistry
Background:
- Domperidone is a dopamine antagonist.
- Guanosine triphosphate (GTP) analogs modulate dopamine receptor activity.
- Rat striatum and pituitary are key brain regions for dopamine signaling.
Purpose of the Study:
- To characterize 3H-Domperidone binding sites in rat striatum and pituitary.
- To investigate the influence of Gpp(NH)p on these binding sites.
- To compare the effects of various dopamine antagonists on 3H-Domperidone binding.
Main Methods:
- Radioligand binding assays using 3H-Domperidone.
- Inhibition studies with dopamine and various antagonists.
- Guanosine triphosphate analog (Gpp(NH)p) treatment.
- Computer-aided analysis of binding data.
Main Results:
- Gpp(NH)p induced rightward shifts in dopamine concentration-inhibition curves in both tissues, with greater effects in the pituitary.
- Striatal 3H-Domperidone binding resolved into high- and low-affinity sites, while pituitary binding showed only a low-affinity site.
- Discriminant benzamide derivatives identified distinct receptor components in the striatum, differentiating them from the pituitary.
Conclusions:
- Rat striatum and pituitary exhibit differential dopamine receptor pharmacology.
- The striatum possesses heterogeneous 3H-Domperidone binding sites, unlike the pituitary.
- These findings contribute to understanding dopamine receptor subtypes and their regulation.